BIM
MGNX icon

Bogle Investment Management’s MacroGenics MGNX Stock Holding History

Bogle Investment Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-127,100
Closed -$740K – 378
2020
Q1 		$740K Sell
127,100
-22,439
-15% -$204K 0.08% 180
2019
Q4 		$1.63M Buy
+149,539
New +$1.48M 0.15% 150
2014
Q3 		– Sell
-143,453
Closed -$3.12M – 376
2014
Q2 		$3.12M Buy
+143,453
New +$3.02M 0.21% 136

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bogle Investment Management's MGNX Position: Q2 2020 in Review

Bogle Investment Management sold out of MacroGenics (MGNX) in Q2 2020, closing a stake of 127,100 shares — an estimated $740K sold.

Bogle Investment Management first reported a position in MGNX in Q2 2014 and held it in 3 quarters. The position peaked at $3.12M in Q2 2014. 137 funds tracked by Wall St. Rank hold MGNX as of Q2 2020.

  • Bogle Investment Management reported no remaining MacroGenics position as of Q2 2020 after selling out during the quarter.
  • Bogle Investment Management sold 127,100 MacroGenics shares in Q2 2020, an estimated $740K.
  • Bogle Investment Management first reported a position in MacroGenics in Q2 2014 and held it in 3 quarters.
  • Bogle Investment Management's MacroGenics position peaked at $3.12M in Q2 2014.
  • 137 funds tracked by Wall St. Rank held MacroGenics as of Q2 2020.

Based on Bogle Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.